Onconova Therapeutics, Inc. 4
4 · Onconova Therapeutics, Inc. · Filed Dec 24, 2013
Insider Transaction Report
Form 4
MCKEARN THOMAS J
President, R&D
Transactions
- Award
Stock Option (right to purchase)
2013-12-20+72,000→ 72,000 totalExercise: $13.48Exp: 2023-12-20→ Common Stock (72,000 underlying)
Footnotes (1)
- [F1]These options vest over 4 years in 48 monthly installments.